 |
 |
 |
September 5, 2000
| Company Name | Taisho Pharmaceutical Co., Ltd. |
| Head Office | 3-24-1 Takada, Toshima-ku, Tokyo |
| Representative Director (name and title) |
Akira Uehara, President (First Section of the Tokyo Stock Exchange: Ticker Code 4535) |
| Management Contact | Takayuki Kagami, Accounting Division Trustee |
| TEL | 81-3-3985-1111 (switchboard) |
Notification of the Purchase of Treasury Stock Details of the treasury stock purchase announced yesterday (September 4, 2000) are provided below. 1. Reason for purchase Retirement of stock in accordance with Section 3 of the Commercial Code governing the retirement of shares 2. Type of stock purchased Taisho par-value common stock 3. Amount of stock purchased 2,541,000 shares 4. Price 3,190 yen 5. Date of transaction Tuesday, September 5, 2000 6. Method of purchase Purchased at closing price from ToSTNeT-2 of the Tokyo Stock Exchange We are pleased to announce that this treasury stock purchase was completed as resolved by the Board of Directors on September 4, 2000. |
